1. Home
  2. ROL vs UTHR Comparison

ROL vs UTHR Comparison

Compare ROL & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rollins Inc.

ROL

Rollins Inc.

HOLD

Current Price

$52.54

Market Cap

26.5B

Sector

Finance

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$522.84

Market Cap

23.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROL
UTHR
Founded
1948
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.5B
23.9B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
ROL
UTHR
Price
$52.54
$522.84
Analyst Decision
Buy
Buy
Analyst Count
10
14
Target Price
$66.10
$533.21
AVG Volume (30 Days)
2.4M
515.9K
Earning Date
04-22-2026
04-29-2026
Dividend Yield
1.38%
N/A
EPS Growth
13.54
13.07
EPS
1.09
27.86
Revenue
$2,161,220,000.00
$1,483,300,000.00
Revenue This Year
$10.42
$7.05
Revenue Next Year
$8.81
$13.30
P/E Ratio
$48.51
$19.10
Revenue Growth
7.23
2.38
52 Week Low
$51.77
$266.98
52 Week High
$66.14
$549.50

Technical Indicators

Market Signals
Indicator
ROL
UTHR
Relative Strength Index (RSI) 26.74 51.98
Support Level N/A $464.92
Resistance Level $58.38 $542.66
Average True Range (ATR) 1.21 13.01
MACD -0.14 -1.45
Stochastic Oscillator 4.13 11.73

Price Performance

Historical Comparison
ROL
UTHR

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: